Limor Amit

Summary

Publications

  1. ncbi The impact of Bevacizumab (Avastin) on survival in metastatic solid tumors--a meta-analysis and systematic review
    Limor Amit
    Institute of Oncology, Rabin Medical Center, Beilinson Campus, Petach Tiqwa, Israel
    PLoS ONE 8:e51780. 2013

Detail Information

Publications1

  1. ncbi The impact of Bevacizumab (Avastin) on survival in metastatic solid tumors--a meta-analysis and systematic review
    Limor Amit
    Institute of Oncology, Rabin Medical Center, Beilinson Campus, Petach Tiqwa, Israel
    PLoS ONE 8:e51780. 2013
    ..To evaluate the effect of Bevacizumab in combination with chemotherapy on overall survival of patients with metastatic solid tumors...